Skip to main content

Table 1 Details of subjects with pulmonary Mycobacterium avium complex disease and dosage of each drug

From: Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes

Subject

Gender

Age (years)

Weight (kg)

Species

Dosage (mg/day)

CAM

RFP

EB

A

female

68

58

M.avium

800

600

750

B

male

70

64

M.avium

800

450

750

C

female

68

43

M.avium

600

450

500

D

female

64

42

M.avium

800

450

500

E

female

50

51

M.intracellulare

800

450

750

F

female

63

47

M.avium

800

450

750

G

female

70

56

M.avium

800

600

750

H

female

71

48

M.avium

800

450

750

I

male

75

47

M.avium and M.intracellulare

800

450

750